Maccura Biotechnology Co.Ltd

Short Term Long Term Short Term Comparison Long Term Comparison
  • 300463
  • 1d0.25%
  • 1w-5.03%
  • 1m-11.33%
  • 1y-34.74%
ATH
  • ATH Price$59.80
  • ATH Date2020-07-10
  • % since ATH-80.10%
  • % to ATH402.50%
ATL
  • ATL Price$10.30
  • ATL Date2024-02-05
  • % from ATL15.53%
  • Last Low Price$10.3
  • Last Low Date2024-02-05
  • % From Last Low15.53%
IPO
  • IPO Price$33.55
  • % Current ROI USD-64.53%
  • ATH Price$59.80
  • % ROI ATH 58,055.44%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="300463"]

Key Data [addtoany]

Current price $11.9
Sector Healthcare
Industry Diagnostics & Research
Today's High/Low $12.48/$11.66
Volume 7,297,087.00
Previous Close $11.87
52 Week High/Low $18.2542/$9.9
Market Cap 7,288,392,704.00
P/E Ratio 19.5082
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0.78
Annualized Dividend $0.0284
$11.9
[addtoany]

Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of IVD products and related services in China and internationally.
The company offers immunoassay products, such as chemiluminescence analyzers and reagents; clinical chemistry reagents for hepatic function, glycometabolism, iron and other, renal function, coagulation, special protein, cardiac, and lipids; and clinical laboratory products, such as automatic hematology, and automatic and semi-automatic coagulation analyzers.
It also provides POCT products, such as fluorescence immunoassay analyzers, as well as colloidal gold kits; molecular diagnosis products, such as PCR and NGS; and pathology products.
The company was founded in 1994 and is based in Chengdu, China.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity